Immunology
-
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients
This article has 18 authors:Reviewed by ScreenIT
-
Analysis of SARS-CoV-2 specific T-cell receptors in ImmuneCode reveals cross-reactivity to immunodominant Influenza M1 epitope
This article has 2 authors:Reviewed by ScreenIT
-
Cross-Neutralization Activity Against SARS-CoV-2 is Present in Currently Available Intravenous Immunoglobulins
This article has 10 authors:Reviewed by ScreenIT
-
Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19
This article has 16 authors:Reviewed by ScreenIT
-
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
This article has 28 authors:Reviewed by ScreenIT
-
Array-based analysis of SARS-CoV-2, other coronaviruses, and influenza antibodies in convalescent COVID-19 patients
This article has 11 authors:Reviewed by ScreenIT
-
Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution
This article has 4 authors:Reviewed by ScreenIT
-
A novel biparatopic antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
This article has 26 authors:Reviewed by ScreenIT
-
Novel ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV2
This article has 8 authors:Reviewed by ScreenIT
-
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
This article has 14 authors:Reviewed by ScreenIT